Futures on the Dow were significantly worse than the S&P 500 because of a cardiovascular drug’s late-stage setback.
Related stories
The yen's sudden surge upsets the carry trade faithful
TPB cancels C&N Southwest Sydney registration over conduct breaches
U.S. stocks usually stumble after Fed hikes, but these markets tend to climb, says Citi
The Stock Market Is Repeating a Pattern Not Seen in Decades. History Says This Will Happen Next.
Kistos secures Royal Decree for Oman Blocks 3 and 4 deal
All about the stunning homes of the Season 35 cast of ‘Dancing With the Stars’